Severity grading system for acute allergic reactions: A multidisciplinary Delphi study
- PMID: 33476673
- PMCID: PMC8273088
- DOI: 10.1016/j.jaci.2021.01.003
Severity grading system for acute allergic reactions: A multidisciplinary Delphi study
Abstract
Background: There is no widely adopted severity grading system for acute allergic reactions, including anaphylactic and nonanaphylactic reactions, thus limiting the ability to optimize and standardize management practices and advance research.
Objective: The aim of this study was to develop a severity grading system for acute allergic reactions for use in clinical care and research.
Methods: From May to September 2020, we convened a 21-member multidisciplinary panel of allergy and emergency care experts; 9 members formed a writing group to critically appraise and assess the strengths and limitations of prior severity grading systems and develop the structure and content for an optimal severity grading system. The entire study panel then revised the grading system and sought consensus by utilizing Delphi methodology.
Results: The writing group recommended that an optimal grading system encompass the severity of acute allergic reactions on a continuum from mild allergic reactions to anaphylactic shock. Additionally, the severity grading system must be able to discriminate between clinically important differences in reaction severity to be relevant in research while also being intuitive and straightforward to apply in clinical care. Consensus was reached for all elements of the proposed severity grading system.
Conclusion: We developed a consensus severity grading system for acute allergic reactions, including anaphylactic and nonanaphylactic reactions. Successful international validation, refinement, dissemination, and application of the grading system will improve communication among providers and patients about the severity of allergic reactions and will help advance future research.
Keywords: Allergic reactions; Delphi; anaphylaxis; emergency department; severity.
Copyright © 2021 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Figures
Comment in
-
Anaphylaxis-moving beyond severity….J Allergy Clin Immunol. 2021 Jul;148(1):83-85. doi: 10.1016/j.jaci.2021.04.017. Epub 2021 Apr 23. J Allergy Clin Immunol. 2021. PMID: 33901514 No abstract available.
-
Severity grading system for acute allergic reactions-time for validation and assessment of best practices.J Allergy Clin Immunol. 2021 Jul;148(1):86-88. doi: 10.1016/j.jaci.2021.04.031. Epub 2021 May 6. J Allergy Clin Immunol. 2021. PMID: 33965430 No abstract available.
References
-
- Shaker MS, Wallace DV, Golden DBK, Oppenheimer J, Bernstein JA, Campbell RL, et al. Anaphylaxis—a 2020 practice parameter update, systematic review, and Grading of Recommendations, Assessment, Development and Evaluation (GRADE) analysis. J Allergy Clin Immunol 2020;145:1082–123. - PubMed
-
- The PALISADE Group of Clinical Investigators. AR101 oral immunotherapy for peanut allergy. N Engl J Med 2018;379:1991–2001. - PubMed
-
- Leung DYM, Sampson HA, Yunginger JW, Burks AW, Schneider LC, Wortel CH, et al. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med 2003;348:986–93. - PubMed
-
- Michelson KA, Dribin TE, Vyles D, Neuman MI. Trends in emergency care for anaphylaxis. J Allergy Clin Immunol Pract 2020;8:767–8.e2. - PubMed
-
- Bilaver LA, Chadha AS, Doshi P, O’Dweyer L, Gupta RS. Economic burden of food allergy- a systematic review. Ann Allergy Asthma Immunol 2019;122:373–80. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
